Seeking Alpha

Optimer Pharmaceuticals (OPTR) announces positive results from a pair of Phase 3 trials on the...

Optimer Pharmaceuticals (OPTR) announces positive results from a pair of Phase 3 trials on the benefits of its fidaxomicin tablets compared to oral vancomycin for cancer patients.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)